Limitation of combination therapy of Interferon and Ribavirin for older patients with chronic hepatitis C
5th Jan 2006, 22:39 GMT
A new Japanese study examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower long-term benefits in this age group.
Limitation of combination therapy of Interferon and Ribavirin for older patients with chronic hepatitis C related news:
- Difficulty in treating older hepatitis C patients with combination therapy — EurekAlert! - Medicine and Health
- Cyclosporine inhibits hepatitis C virus in vitro — EurekAlert! - Medicine and Health
- Cyclosporine suppresses hepatitis C virus and increases the chance of a sustained virological response after liver transplantation — News-Medical News Feed
- Older Hepatitis C Patients Prove Difficult to Treat — RedOrbit News - Health
- REVIEW ARTICLE: Medical Progress: Autoimmune Hepatitis — New England Journal of Medicine -- Recent Issues
- Viral Hepatitis Conference to Take Place February 27-28, 2006 in Boston, MA — RedOrbit News - Health
- Idenix, Novartis seek approval for chronic hepatitis B treatment — Boston Globe -- Business News
- Volume 42, number 3: Severe or Fatal Liver Injury in 50 Patients in the United States Taking Rifampbin and Pyrazinamide for Latent Tuberculosis Infection — Clin Infect Dis Latest Issue
- Evidence supports combination therapy for achieving remission of early rheumatoid arthritis — News-Medical News Feed
- New Chemotherapy Regimen Improves Survival for Advanced Ovarian Cancer Patients — Blogcritics
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info